Asosiy kontentga oʻtish
Maqola

Phase I/II study evaluating the safety and clinical efficacy of temsirolimus and bevacizumab in patients with chemotherapy refractory metastatic castration-resistant prostate cancer

Pedro C. BarataTulane University, New Orleans, LA, USAMatthew M. CooneySeidman Cancer Center, Case Comprehensive Cancer Center, University Hospitals, Cleveland, OH, USAPrateek MendirattaCase Comprehensive Cancer CenterRuby GuptaCleveland Clinic Taussig Cancer Institute, 9500 Euclid Ave/CA60, Cleveland, OH, 44195, USARobert DreicerDivision of Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, VA, USAJorge A. GarcíaCleveland Clinic Taussig Cancer Institute, 9500 Euclid Ave/CA60, Cleveland, OH, 44195, USA. [email protected]
2018en

Ochiq kirish: yoʻq

ABI

Annotatsiya

Annotatsiya mavjud emas.

Identifikatorlar

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba